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Objective: This study examined midterm results after treatment with the endovascular Talent thoracic stent graft
(Medtronic/AVE, Santa Rosa, Calif) in patients with acute or chronic aortic dissection.
Methods: In the Talent Thoracic Retrospective Registry, 180 patients were treated for acute or chronic aortic dis-
section (mean age: 59.6 13.0 years). Thirty-seven (20.6%) patients had acute aortic complications with signs of
rupture, distal malperfusion, or persistent pain; the remainder were in stable condition. Aortic diameter was 53.5
 14.3 mm, the distance from the left subclavian artery to the proximal entry tear was 44.1  41.9 mm, and dis-
section extended beyond the celiac axis in 88.3% of cases. Length of covered aorta measured 138.9  45.7 mm,
with one stent graft used in 125 (69.4%) patients.
Results: Procedural success was 98.3%. Nine patients died within 30 days, yielding an overall early mortality of
5.0%. For in-hospital outcome, multivariate analysis showed that age greater than 75 years (odds ratio [OR] 4,9;
95% confidence intervals [CI] 1.6–15.1; P ¼ .006), American Society of Anesthesiologists class greater than III
(OR 2.8; 95% CI 1.0–7.5; P¼ .04), and emergency status (OR 3.5; 95% CI 1.3–8.9; P¼ .01) were independent
predictors of major adverse events. Compared with electively treated patients, emergency status was associated
with a higher incidence of in-hospital mortality (13.5% vs 2.1%; P ¼ .003) and neurologic events (16.2% vs
4.2%; P¼ .01). However, patients with acute dissection had a smaller baseline diameter and were less often iden-
tified to have secondary endoleaks and progressive enlargement. Average follow-up for hospital survivors was
22.3  17.0 months with an estimated survival of 94.9%  1.7% at 30 days, 90.6%  2.3% at 12 months,
90.6%  2.3% at 24 months, and 81.8%  4.8% at 36 months. During follow-up, 30 patients required a total
of 32 secondary interventions including 12 open and 20 endovascular procedures, accounting for an estimated
71.5% freedom from reinterventions at 36 months. Follow-up imaging revealed stable or decreasing thoracic aor-
tic diameter in 80.5% of patients.
Conclusion: Endovascular treatment for aortic dissection is associated with reasonably low morbidity and mor-
tality. Long-term surveillance is crucial to define more comprehensively the durability of stent graft treatment of
aortic dissection and to determine which patients are appropriate candidates for stent graft therapy.EAortic dissection remains a catastrophic cardiovascular
event associated with high morbidity and mortality rates.1
Improved diagnostic techniques and refined management
strategies have shown potential to improve diagnosis and
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have contributed to understand epidemiology and patho-
physiology of aortic dissection.2-4 Different from proximal
dissection, however, management of patients with distal dis-
section (Stanford type B) remains a matter of ongoing de-
bate.5,6 Contemporary mortality rates of surgical resection
of the descending aorta range between 0% and 27% for
elective cases and exceed 50% in complicated aortic dissec-
tion under emergency conditions.1,7 Similar to demographic
changes in the Western world, the population at risk is aging
with an increasing variety of comorbidities portending an in-
cremental risk. Today, most institutions favor a complica-
tion-specific approach with medical treatment as the
primary therapeutic option, while reserving surgery for
evolving complications (eg, persistent pain, false lumen ex-
pansion, visceral or peripheral malperfusion, or [imminent]
rupture).5 Even without complications, however, both
short-term and long-term prognoses of type B aortic dissec-
tion remain sobering despite optimal medical therapy.ardiovascular Surgery c Volume 138, Number 1 115
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CT ¼ computed tomography
MRI ¼ magnetic resonance imaging
OR ¼ odds ratio
TTR ¼ Talent Thoracic Retrospective Registry
Survivals at 3 years decrease to 75%8,9; uncontrolled hyper-
tension, advanced age, and persistent perfusion of the false
lumen have been identified as predictors of adverse out-
come.10,11 In this scenario, endovascular stent grafting has
emerged as an attractive therapeutic concept even in patients
unfit for open surgery.12,13 Several single-center reports
have shown feasibility and clinical safety, thus emphasizing
endovascular repair for aortic dissection.14-16 In the absence
of final data from randomized trials,17 smoldering critique is
ongoing with concerns of device failure and long-term dura-
bility of stent grafts.
The Talent Thoracic Retrospective Registry (TTR) was
designed to collect outcome data from patients who under-
went endoluminal treatment with the Talent thoracic stent
graft (Medtronic/AVE, Santa Rosa, Calif) in 7 European re-
ferral centers.2 Clinical and imaging follow-up data were
collected with particular reference to mortality and midterm
complications. The present subanalysis of the TTR registry
comprises data on patients subjected to endovascular stent
graft placement for acute or chronic aortic dissection.
PATIENTS AND METHODS
Enrolment
The current analysis from the TTR registry is focused on 180 consecutive
patients who underwent endovascular repair with the Talent thoracic stent
graft for aortic dissection between November 1996 and March 2004. This
subgroup represents 39.4% from a total of 457 patients with thoracic aortic
disease collected for the TTR registry. Seven European referral centers (Bo-
logna, Lille, Marseille, Nieuwegein, Rostock, Toulouse, and Vienna) pro-
vided data from patients treated consecutively for thoracic aortic disease.
The TTR registry was approved by the local ethical committee. Follow-
up analysis was formed on clinical and imaging findings until the last visit
and includes all adverse events. Data were collected on case report forms
and checked for inconsistencies. In case of discrepancies, the attending in-
vestigator was queried to ensure appropriate interpretation of events.
Patient Characteristics
The dissection subgroup of TTR comprises 134 male and 46 female pa-
tients with an age of 59.6 13.0 years, ranging from 22 to 82 years (Table 1).
American Society of Anesthesiologists (ASA) classification greater than
class III was present in 31 (17.2%). Previous aortic surgery or endovascular
aortic repair was reported in 46 (25.6%) patients. The spectrum of aortic dis-
ease implied 171 (95.0%) patients with Stanford type B and 9 (5.0%) pa-
tients with thoracoabdominal type A dissection. All patients with type A
dissection had been previously operated for acute proximal dissection and
were electively treated with descending thoracic stent grafts in the chronic
stage of disease. Comorbid medical conditions comprised chronic hyperten-116 The Journal of Thoracic and Cardiovascular Susion (n¼ 156, 86.7%), renal insufficiency (n¼ 34, 18.9%), chronic obstruc-
tive pulmonary disease (n¼ 23, 12.8%), Marfan syndrome (n¼ 15, 8.3%),
and previous cerebrovascular accidents (n¼ 10, 5.6%). Indications for stent
graft deployment included complicated acute type B dissection in 29 patients
(16.1%), although the majority of patients were treated for chronic dissec-
tion with a diameter more than 5.5 cm (n ¼ 83, 46.1%), rapid progression
greater than 10 mm/year (n¼ 60, 33.3%), and signs of (impending) rupture
(n ¼ 8, 4.4%). On aggregate, 37 patients (20.6%; 29 acute and 8 chronic
dissections) were subjected to emergency repair for symptomatic disease
with signs of (impending) rupture, distal malperfusion, or persistent pain;
all other patients (79.4%) were electively treated in stable condition.
Imaging Before Endovascular Treatment
Before endovascular treatment all patients were examined by at least one
tomographic imaging modality, such as computed tomography (CT) and mag-
netic resonance imaging (MRI), in addition to angiography or transesophageal
echocardiography. Contrast-enhanced CT was the most frequently used diag-
nostic method (61.7%), followed by angiography (61.1%), MRI (47.2%),
and transesophageal echocardiography (27.8%). In 30%of cases only one im-
aging modality was obtained, whereas at least two imaging techniques were
used in 70% of cases. Mean aortic diameter for thoracic dissection was 53.5
 14.3 mm (range 26–136 mm) and the distance from the origin of subclavian
artery to the proximal entry side was 44.1 41.9 mm (range 0–220 mm); dis-
section extended beyond the celiac trunk in 88.3% of cases (Table 1).
TABLE 1. Demographics and clinical baseline characteristics (n ¼
180)
No. %
Male 134 74.4
Age, y (mean  SD) 59.6  13.0 (22–82)
ASA class (>III) 31 17.2
Patient status (acute) 37 20.6
Aortic and aortic valve procedures 46 25.6
Bentall procedure 18 10.0
Ascendens graft 16 8.9
Elephant trunk 4 2.2
Descendens graft 3 1.7
Surgical fenestration 2 1.1
Single AVR 2 1.1
Infrarenal graft 1 0.6
Bare stent abdominal 1 0.6
Comorbidity and etiology
Hypertension 156 86.7
Marfan syndrome 15 8.3
Aortic trauma 5 2.8
Renal insufficiency 34 18.9
COPD 23 12.8
CVA 10 5.6
Smoking 78 43.3
Aortic dissection
Stanford type A 9 5.0
Stanford type B 171 95.0
Abdominal dissection 158 88.3
Mean aortic diameter, mm
(mean  SD, range)
53.5  14.3 (26–136)
Length LSA to entry, mm
(mean  SD, range)
44.1  41.9 (0–220)
SD, Standard deviation; ASA, American Society of Anesthesiologists; AVR, aortic
valve replacement; COPD, chronic obstructive pulmonary disease; CVA, cerebrovas-
cular accident; LSA, left subclavian artery.rgery c July 2009
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The follow-up protocol included contrast-enhanced aortic imaging with
CT or MRI technique before hospital discharge, 6 and 12 months after stent
graft placement, and yearly thereafter. Because the majority of patients were
not followed up in each of the 7 centers, compliance with the imaging sur-
veillance protocol was variable. Follow-up clinical status was obtained by
contacting all surviving patients or family members and their primary
care physician and was 100% complete. Follow-up averaged 22.3  17.0
months (maximum follow-up 71 months; total cumulative follow-up 318
patient-years; 19 patients remained at risk at 4 years).
Definitions
Procedural success was defined as successful deployment of the stent
graft device. Primary success was defined as complete exclusion of the false
lumen without any additional intervention. Secondary success was defined
as complete exclusion of the aneurysm after secondary intervention. Endo-
leak was defined as radiologic evidence of blood flow outside the stent graft
and was classified as primary (diagnosed within 30 days of endovascular re-
pair) or secondary (diagnosed more than 30 days after intervention).
Statistical Analysis
The incidence of adverse events is given as number of patients experi-
encing the event followed by the corresponding percentage. Continuous
data are reported as mean  standard deviation including range. For inter-
group comparison of incidence rates, the 2-sided c2 test was used for cate-
gorical variables. The Kaplan–Meier nonparametric method was used to
generate estimates of survival. Stepwise logistic regression analysis was
performed to determine predictors of predefined clinical end points. Non-
correlated variables with P< .05 at univariate analyses were included in
the multivariate models; model precision was evaluated by the Hosmer–
Lemeshow goodness-of-fit statistic. Results are reported as odds ratios
and 95% confidence intervals (95% CI). Statistical analyses were carried
out with SPSS software package version 15.0 (SPSS, Inc, Chicago, Ill).
RESULTS
Procedural Results
Procedural success was documented in 98.3% of cases; an
endovascular graft could not be deployed in 2 patients with
previous elephant trunk for type A dissection, and stent graft
insertion was impossible in another patient with severely cal-
cified access vessels. Those procedures were terminated at
the discretion of the operator for fear of procedure-related
complications. The mean length of covered aorta was 139
mm, ranging from 28 to 380 mm with only one stent graft
used in 125 (69.4%) patients. In 27 (15.3%) patients the
stent graft was positioned in the distal arch with coverage
of the left subclavian artery to extend the proximal landing
zone; in 18.5% of them (5 patients) ancillary carotid–subcla-
vian bypass surgery was performed before stent graft place-
ment. Adjunctive maneuvers such as side-branch coiling to
prevent type II endoleak or abdominal fenestration for pe-
ripheral malperfusion were performed in 5 patients (Table 2).
Early procedural outcome (30 days). Nine patients died
during hospitalization, yielding an overall in-hospital
mortality rate of 5.0% (9/180). Two of them died during
the endovascular procedure; both had required emergency
treatment for ruptured type B dissection. In-hospital mortal-
ity of patients undergoing stent graft treatment for acuteThe Journal of Thoracic and Ccomplications was higher than that for those receiving elec-
tive therapy (13.5% vs 2.1%; P¼ .003). Multivariate logis-
tic regression analysis showed that ASA class greater than
III (odds ratio [OR] 10.9; 95% CI 2.4–49.6; P ¼ .002)
and age greater than 75 years (OR 8.7; CI 1.8–42.5; P ¼
.007) were independent predictors of 30-day mortality. For
in-hospital outcomes, multivariate logistic regression analy-
sis revealed age greater than 75 years (OR 4.9; 95% CI 1.6–
15.1; P¼ .006), ASA class greater than III (OR 2.8; 95% CI
1.0–7.5; P ¼ .04), and emergency status (OR 3.5; 95% CI
1.3–8.9; P ¼ .01) as independent predictors of in-hospital
adverse events (Table 3). Early emergency conversion was
required in 3 patients with retrograde type A dissection
and in 2 patients with rapidly enlarging false lumen and
TABLE 2. Procedural detail and 30-day outcome
No. %
Procedural success 177 98.3
Length of covered aorta, mm (mean  SD) 138.9  45.7
(28–380)
No. of stent grafts used
Zero 3 1.7
One 125 69.4
Two 40 22.2
Three 11 6.1
Four 1 0.6
Occlusion of LSA 27 15.3
With previous revascularization 5
Without previous revascularization 22
Early mortality
Thirty-day mortality 9 5.0
Intraprocedural death 2 1.1
Adjunctive intraprocedural maneuvers
Side branch coiling (LSA, lusorian) 3 1.7
Fenestration of abdominal aorta 2 1.1
Procedural failure and redo, intervention
Impossibility to insert or deploy stent graft 3 1.7
Conversion to aortic surgery 5 2.8
Additional stent graft 2 1.1
Primary endoleak 52 29.4
Vascular local procedures
Revision of retroperitoneal hematoma 1 0.6
Subclavian to carotid transposition 1 0.6
Iliofemoral bypass 1 0.6
Iliorenal bypass 1 0.6
Early complications
Neurologic 12 6.7
Stroke 7 3.9
Spinal cord ischemia 5 2.8
Cardiorespiratory failure 6 3.3
Vascular local 4 2.2
Retrograde dissection 4 2.2
ARDS 2 1.1
Pulmonary embolism 1 0.6
Multiorgan failure 1 0.6
Length of hospital stay (d) 12.7  10.6
LSA, Left subclavian artery; ARDS, adult respiratory distress syndrome.ardiovascular Surgery c Volume 138, Number 1 117
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a 30-day conversion rate of 2.8%. Finally, in 2 patients
with impending rupture, satisfactory exclusion of the false
lumen was achieved by additional sealing with an overlap-
ping second stent graft. Periprocedural stroke was docu-
mented in 7 (3.9%) patients. Spinal cord ischemia was
observed in 5 (2.8%) but was not significantly associated
with the use of multiple stent grafts, coverage of the left sub-
clavian artery, or emergency condition. At follow-up, spinal
cord damage resolved completely in 2 of 5 patients.
Mortality and aortic rupture at midterm. Mean follow-
up period for hospital survivors was 22.3  17.0 months
(1.0–71.0 months) (Table 4); in 64.9% of patients more
than 12 months of clinical and imaging follow-up was avail-
able. Late death occurred in 11 of 168 (6.5%) patients and
was related to rupture in 7 (63.6%). In these patients aortic
death was related to spontaneous rupture of the ascending
aorta (n ¼ 1), retrograde type A dissection (n ¼ 1), and rup-
ture of a descending false lumen (n ¼ 5). Other causes of
deaths included stroke, bronchial carcinoma, and myocar-
dial infarction. Kaplan–Meier overall survival was 94.9%
 1.7% at 30 days, 90.6%  2.3% at 12 months, 90.6%
 2.3% at 24 months, and 81.8% 4.8% at 36 months. Es-
timates for freedom from aortic rupture were 99.4% 0.6%
at 30 days, 95.0% 1.9% at 12 months, 95.0% 1.9% at
24 months, and 89.6%  4.1% at 36 months (Figure 1). In
multivariate logistic regression analysis, poor clinical health
TABLE 3. Predictors of 30-day-mortality and in-hospital adverse
events
Univariate Multivariate
Analysis P value OR 95% CI P value
Thirty-day mortality
ASA class (>III) <.001 10.9 2.4–49.6 .002
Age (>75 y) <.001 8.7 1.8–42.5 .007
Male .39
Emergency status .003
Traumatic aortic injury .63
Diameter (>65 mm) .49
Marfan syndrome .39
Type of dissection .51
Relevant aortic surgery .09
Occluded LSA .22
In-hospital complications
ASA class (>III) <.001 2.8 1.0–7.5 .04
Age (>75 y) <.001 4.9 1.6–15.1 .006
Male .02
Emergency status <.001 3.5 1.3–8.9 .01
Traumatic aortic injury .84
Diameter (>65 mm) .24
Marfan syndrome .72
Type of dissection .65
Relevant aortic surgery .20
Occluded LSA .82
OR, Odds ratio; CI, confidence intervals; ASA, American Society of Anesthesiologists;
LSA, left subclavian artery.118 The Journal of Thoracic and Cardiovascular Sustatus (ASA class>III; OR 3.8, 95% CI 1.4–10.6; P¼ .01)
and older age (>70 years, OR 3.0, 95% CI 1.1–8.1; P ¼
.028) were the only significant predictors of late death.
Secondary procedures. During follow-up, 30 patients re-
quired a total of 32 additional interventions including 12
late surgical conversions and 20 adjunctive endovascular
procedures. Thus, the total reintervention rate was 17.9%
(30/168) for survivors of index hospitalization. Indication
for open surgery included presence of endoleaks (n¼ 6), en-
largement of the distal false lumen (n ¼ 2), retrograde type
A dissection (n ¼ 2), hybrid aortic arch procedure (n ¼ 1),
and recurrent dissection of the ascending aorta (n ¼ 1) after
failed glue reconstruction. All patients survived the surgical
procedure without related fatalities. Univariate predictors for
late conversion to surgery were Marfan syndrome (P <
.001), secondary endoleak (P ¼ .015), diameter greater
than 60 mm (P ¼ .032), and age of 65 years or older (P ¼
.04). In multivariate logistic regression analysis, Marfan
syndrome was the only independent predictor of late conver-
sion (OR 32.3; 95% CI 6.0–175.2; P< .001). Additionally,
20 catheter-based interventions were performed during fol-
low-up, again with no in-hospital mortality. Fifteen patients
required a second stent graft for persisting false lumen flow
(n¼ 13) or aortic ulcer (n¼ 2). One patient with developing
aneurysm of the aortic arch underwent a hybrid procedure
with proximal stent graft extension after head vessel de-
branching; in another 3 patients endoleaks were sealed
with coil embolization. Stenting of both renal arteries was
performed to restore organ perfusion in 1 patient with acute
renal failure owing to shifting of dissection lamella. The
presence of primary (P ¼ .027) or secondary endoleak
(P<.001), diameter greater than 60 mm (P¼ .015), and pre-
vious aortic surgery (P¼ .042) were univariate predictors of
TABLE 4. Follow-up data (22.3 ± 17.0 months) in 168 patients
No. %
Mortality
Overall 11 6.5
Related 7 4.2
Procedural failure
Persistent primary endoleak 33 19.6
Persistent secondary endoleak 8 4.8
Fatal aortic rupture 7 4.2
Retrograde extension 3 1.8
Conversion to surgery 12 7.1
Second stent graft 15 8.9
Stent graft complications
Migration 1 0.6
Modular disconnection 1 0.6
Altered graft integrity 0 0.0
Stent fracture 0 0.0
Change in diameter (n ¼ 164)
Increase 32 19.5
Decrease 41 25.0
No change 91 55.5rgery c July 2009
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endoluminal reintervention was 94.7%  1.7% at 30 days,
83.5% 3.1% at 12 months, 75.5% 4.0% at 24 months,
and 71.5%  4.7% at 36 months (Figure 2).
Imaging follow-up. Primary endoleak was documented in
52 of 177 (29.4%) patients. However, 7 endoleaks sealed
spontaneously during follow-up, whereas an adjunctive en-
dovascular treatment with stent graft extension (7 patients)
or embolization (3 patients) allowed complete resolution of
endoleak in 7 patients. Five cases of primary endoleak and
aneurysm expansion were converted to open surgical repair.
Therefore, the rate of persistent primary endoleak for in-hos-
pital survivors was 19.6% (33/168 patients). Endoleak type I
was most common (86.5%), whereas the incidence of both
type II (11.5%) and type III (1.9%) was low. Secondary en-
doleak (types I and III) was reported in 17 of 168 (10.1%) pa-
tients who had survived the early postoperative course.
Adjunctive stent graft treatment allowed successful endoleak
sealing in 5 of 6 patients; an additional 4 patients underwent
conversion to open repair for progressive false lumen en-
largement. Seven patients did not undergo treatment for sec-
ondary endoleak; among them, no case of spontaneous
resolution was recorded. As a result, persistent secondary
perigraft flow was documented in 8 (4.8%) patients.
The dynamics of aneurysm dimension were reported in 164
patients. Among them, stable (n¼ 91) or decreasing (n¼ 41)
aortic diameter was reported in a total of 132 (80.5%) patients,
whereas 32 (19.5%) patients showed an increase of the aneu-
rysmal process. Migration of a single stent graft was observed
in1 patient,who was converted toopensurgery for a secondary
type I endoleak. In addition, follow-up imaging visualized late
modular disconnection in another patient, who had a lethal
aortic rupture. Alteration of the graft material or detachment
of nitinol frames was not identified.
Interventions in an elective versus an emergency setting.
Patients with thoracic aortic emergencies had a worse gen-
eral health status than patients having elective operationsThe Journal of Thoracic and C(ASA> III, 48.6 vs 9.1%; P< .001). The overall survival
after emergency stent grafting in 37 patients was 86.2% 
5.7% at 30 days, 83.2%  6.3% at 12 months, and
83.2% 6.3% at 3 years, respectively. Survival for patients
in an elective setting was 97.1% 1.4% at 30 days, 92.6%
 2.4% at 12 months, and 81.9%  5.5% at 3 years, re-
spectively (Figure 3). In-hospital complications, including
fatal and nonfatal major adverse events, were documented
more frequently in symptomatic patients requiring instanta-
neous endovascular treatment (40.5% vs 10.5%; P<.001).
Particularly, neurologic events were reported more often in
this subgroup (16.2% vs 4.2% in elective cases; P ¼ .01).
Patients with emergency status had a smaller baseline diam-
eter and were less often identified to have secondary endo-
leaks. Accordingly, those patients revealed a significantly
lower rate of progressive aortic enlargement when compared
with electively treated patients (3.2% vs 23.3%; P ¼ .001).
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secondary procedures and fatal aortic rupture after stent graft
repair for acute aortic dissection.
Stent grafts after surgical treatment of type A dissection.
Nine patients were electively treated for persistent distal
false lumen flow after previous surgery for type A dissec-
tion. Among them, Marfan syndrome (44.4% vs 6.4%;
P < .001) and baseline diameter greater than 60 mm
(55.6% vs 21.6%; P¼ .019) were reported more frequently
when compared with those of patients with type B dissec-
tion. Previous diagnosis of type A dissection did not increase
in-hospital complications and early mortality rate after stent
graft treatment. In contrast, primary endoleaks were detected
more often in patients with type A dissection (66.6% vs
27.4% in type B; P ¼ .012), resulting in a higher rate of
chronic enlargement (44.4% vs 17.2%; P ¼ .042) and rup-
ture (22.2% vs 4.1%; P¼ .015). Consistently, endovascular
and open reinterventions for procedural failure were re-
ported more often in patients with previous type A dissec-
tion. However, at midterm, overall mortality rate of type A
dissection was not significantly higher than for classic type
B dissection.
Retrograde extension of type B dissection. Retrograde
extension of type B dissection was documented in 7 patients
after endovascular treatment; in 3 cases, the patient had been
treated under emergency conditions. Retrograde extension
occurred within 30 days in 4 of 7 (57.1%) patients. Five pa-
tients were operated on and survived the complex procedure
without major complications. The remaining 2 patients died
before transfer to the operating theater. In multivariate logis-
tic regression analysis, use of more than one stent graft was
the only independent predictor for retrograde extension of
aortic dissection (OR 7.6; 95% CI 1.3–43.9; P ¼ .023).
DISCUSSION
In 1999, endovascular treatment of type B dissections
with stent graft technology was first described in two
seminal reports, raising optimism for improved early and
FIGURE 3. Survival after stent graft treatment in thoracic emergencies
versus an elective setting.120 The Journal of Thoracic and Cardiovascular Sulate survival.12,13 The concept was propelled by the desire
to induce aortic remodeling after sealing the proximal entry
tear, redirecting flow into the true lumen, and promoting de-
pressurization and thrombosis of the false lumen. In addi-
tion, such an approach may effectively treat malperfusion
syndrome by re-establishing side branch flow in dynamic
obstruction.18,19 Growing experience with endovascular
treatment in the spectrum of aortic dissection has confirmed
both feasibility and usefulness, especially in unstable pa-
tients, with encouraging early and midterm results.20 How-
ever, residual perigraft flow and late reperfusion of the
false lumen have been observed occasionally, underlining
the need for stringent follow-up imaging and additional stent
graft placement in selected patients.21
Our analysis focuses on 180 patients with thoracic aortic
dissection extracted from the TTR registry and demon-
strates that endovascular repair using the Talent stent graft
is feasible, with high technical success rates and low inci-
dence of associated complications. Early postinterventional
results are consistent with previous observational evidence
with an in-hospital mortality of 5.0%, including 37 patients
treated for complications under emergency conditions. Our
results indicate that early outcome after endovascular repair
significantly depends on pre-existing conditions. Patients
undergoing urgent stent graft placement for complicated
dissection were found to be at higher risk for major in-hos-
pital complications than those treated in an elective setting
(40.5% vs 10.5%; P< .001). Accordingly, emergency in-
terventions were often prompted by complications of the
dissection with an inherently increased individual risk as
compared with chronic dissection. Our findings are consis-
tent with a recently published meta-analysis showing
higher in-hospital mortality in patients undergoing stent
graft placement for acute dissection than for chronic dissec-
tion. Conversely, patients treated for acute complication of
dissection have a greater potential for aortic remodeling
(Figure 4), which is consistent with previous observations
that false lumen obliteration after stent graft placement
was more frequently achieved in patients with acute dissec-
tion than in patients treated for chronic disease.3,22,23 On
the other hand, we confirm feasibility of successful endo-
vascular procedures with satisfactory clinical outcome in
chronic dissection (Figure 5). However, patients with
chronic dissection more often seem to require late surgical
or endovascular reinterventions and also have more late
complications.
In the TTR registry, persistent paraplegia occurred in only
3 (1.7%) patients. Different from previous reports, enduring
spinal injury was not associated with use of multiple endog-
rafts, previous aortic surgery, or emergency stent grafting. In
addition, the registry confirms a 3.9% incidence of peripro-
cedural stroke, similar to previous observations.3,24,25 It is
commonly believed that stroke is related to difficult ad-
vancement and manipulation of the guide wire or stent graftrgery c July 2009
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Kische et al Evolving Technology/Basic ScienceFIGURE 4. Contrast-enhanced CT of acute type B dissection (A) and comparable CT scans 1 week (B) and 9 months (C) after thoracic stent graft placement
demonstrating complete obliteration and progressive resolution of the false lumen down to the level of celiac trunk (aortic remodeling).Edelivery system within the aortic arch. Technical develop-
ments and miniaturization of the relatively rigid stent graft
devices will thus be even more relevant for treating degener-
ative aneurysmal diseases than for aortic dissection. Our
analysis shows that periprocedural stroke was significantly
associated with increased age, emergency stent grafting,
and higher ASA class. With regard to intentional left subcla-
vian artery occlusion, accumulated observational evidence
suggests this approach may be justified when required for
proximal anchoring of the stent graft in the absence of su-
pra-aortic vascular diseases.26 In dissection, prophylactic
surgical revascularization appears not to be imperative for
safety reasons and can be relegated to an elective measure
after the intervention when symptoms of ischemia occur.
In this registry, subclavian bypass was necessary in only 1
patient with sustained malperfusion of the left arm after
left subclavian artery occlusion.
Similar to previous reports,27 retrograde extension of
the dissection into the ascending aorta, potentially caused
by stent graft–induced intimal injury, has been replicatedThe Journal of Thoracic and Cin 7 patients in the registry, which represent 3.9% of pa-
tients with an overall mortality rate of 28.6%. It is, how-
ever, unclear whether retrograde dissection after stent graft
repair is a true complication or suggestive of progressive
disease.
Besides reasonable short-term outcome, long-term sur-
vival is the key issue of endovascular reconstruction in aortic
dissection. For midterm outcome at 36 months, the Kaplan–
Meier plot indicates an 81.8% overall survival and an
89.9% estimated freedom from aortic fatalities after endo-
vascular reconstruction. Long-term results confirm that
poor clinical health status and older age were independent
predictors of life expectancy after stent graft placement. In
chronic dissection and elective settings, stent grafting fails
to abolish the false lumen in about a quarter of patients, sug-
gesting that it may not be a definitive treatment option. Yet,
there is a continued risk of late aortic rupture (about 4% dur-
ing follow-up) after stent graft placement and need for
secondary aortic procedures in about 20% of patients.
However, among those, only 12 patients required openardiovascular Surgery c Volume 138, Number 1 121
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Evolving Technology/Basic Science Kische et alFIGURE 5. Serial CT imaging study demonstrating rapid false lumen enlargement within 3 months after the index hospitalization for acute type B dissection
(A and B). Stent graft placement within chronic stage of disease enabled complete restoration of compressed true lumen and abolition of false lumen flow (C).surgical repair whereas the majority of reinterventions were
successfully managed endovascularly. Considering both
open and auxiliary endovascular maneuvers, estimated free-
dom from reintervention was 71.5% at 36 months after ini-
tial stent graft implantation. Nevertheless, late aortic rupture
and the need for secondary endovascular or surgical inter-
ventions may also be related to the progressive nature of
the disease and may not necessarily reflect treatment failure.
This is supported by the fact that 11% to 20% and 10% to
44% of patients with type B dissection require repeat sur-
gery when treated medically or surgically, respectively. No-
tably, among all variables, Marfan syndrome was the only
independent predictor of late surgical conversion in this se-
ries comprising 15 Marfan patients. Because of the inherent
fragility of the aortic wall, endovascular treatment in patients
with Marfan syndrome remains controversial.28,29 From
a technical point of view, stent graft deployment was safe
even in patients with Marfan syndrome and peri-interven-
tional outcomes were satisfactory. Conversion to surgery
in 6 patients and late aortic rupture in 3 patients, however,
underscore that stent grafting should be considered a bridg-
ing maneuver to avoid (emergency) repeat surgery rather
than a curative procedure. Furthermore, with the appearance
of secondary endoleaks in about 50% of patients, both close
surveillance and repeated imaging of the aorta appear man-122 The Journal of Thoracic and Cardiovascular Sudatory to detect silent postinterventional complications
eventually requiring additional maneuvers.
Experience with previously operated type A dissection
and endovascular treatment in the chronic stage is rare.
Our registry encompasses 9 patients with type A dissection
treated endovascularly for residual distal false lumen flow.
Although the favorable in-hospital survival and the low in-
cidence of neurologic complications appear to be somewhat
encouraging, it should be noted that 66.6% of patients en-
countered major adverse events, including redo procedures
in 6 patients and fatal aortic rupture in 2 patients.
The present review has some limitations; owing to the
retrospective nature, there was no control over the inclusion
criteria for any endovascular procedure. The absence of
a randomized or concurrent control group precluded direct
comparison with conventional open repair or exclusive med-
ical therapy. In addition, if we are to make any significant
conclusions regarding the durability of endovascular ther-
apy, it will be necessary to obtain longer term follow-up in-
formation. The currently available data on follow-up
outcomes fail to provide precise morphologic information
and rather focus on clinical end points. Therefore, distinct
morphoanatomic long-term surveillance is important to as-
ses any causal relationship between morphology and out-
comes. Further investigation is crucial to understand thergery c July 2009
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ment in patients with thoracic aortic dissection.
In conclusion, endovascular treatment for thoracic aortic
dissection with the Talent stent graft carried out at high-vol-
ume referral centers is associated with low early morbidity
and mortality rates also for patients at high risk and treated
on an emergency basis. Follow-up data indicate a satisfactory
midterm durability of the procedure with an estimated
95.0% freedom from related death and an estimated
75.5% freedom from secondary interventions at 2 years. Al-
though preliminary data suggest that stent graft repair may
ultimately become the treatment of choice for most patients
with distal dissections, the available evidence to date does
not justify indiscriminate use of this technology in patients
currently managed with medical therapy alone. Long-term
surveillance will be crucial to discover complications unique
to thoracic endovascular interventions and to determine
which patients are appropriate candidates for stent graft
therapy. Most important, comparative clinical trials are
clearly needed to clarify the role of stent graft repair in the
setting of both acute and chronic distal dissection.
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Discussion
Dr R. Scott Mitchell (Stanford, Calif). I congratulate you on
a truly fine presentation. It is a difficult subject. You and your co-
authors report on a subject of great interest, that is, the long-term
utility of endografts in both acute and chronic dissections. Al-
though stent grafts may be truly lifesaving for patients with acute
dissections who have malperfusion or impending rupture, many
of us harbor significant reservations regarding their utility in un-
complicated type B dissections or in any chronic dissection. In
this respect, 20% of your patients were treated urgently for acute
complications, whereas the remainder were treated in a stable con-
dition. In-hospital mortality occurred in 5% of patients, 2 of whom
died intraoperatively from ruptures of their dissection, which al-
ways is a very challenging patient cohort. Not surprisingly, older
age, emergency status, and increasing ASA scores were indepen-
dent predictors. Four patients had retrograde type A dissections
in the acute phase, and 2 other patients had late type A dissections.
This brings me to my first question. Do you have any informationCardiovascular Surgery c Volume 138, Number 1 123
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Did they get ballooning at the proximal anastomosis or proximal
extensions? Can you elucidate on that?
Dr Ehrlich. Four of 7 patients had retrograde type A dissection
within 30 days, and there is no doubt that this complication was as-
sociated with the stent-graft implantation. The only predictor that
turned out to be statistically significant was the use of more stents,
speculating that most of those patients did not have a sealing of the
primary tear in the first place. An additional stent was positioned in
the proximal arch with balloon dilatation, and as a consequence of
the procedure an intimal tear with retrograde dissection developed.
With regard to the 3 patients who had retrograde type A dissec-
tion after discharge, we can only speculate that it might have been
some complication of the stent-graft treatment. All of those patients
were operated on, and a new type A dissection developed in some
of them, but we do not have any information on those 3 patients.
DrMitchell. Overall, as you noted, early results were good, but
the late results are of more interest. Here, unfortunately, informa-
tion is more limited. Although survival at 36 months was 81%,
this is a limited measure of success inasmuch as 80% of these pa-
tients were really treated in the uncomplicated and asymptomatic
state. More important would be what happened to the aortas in these
chronic dissections? You tell us that despite a 20% incidence of pri-
mary type I endoleaks, an increase in aortic size occurred in only
20% of patients, and 55% and 25%, respectively, showed no
change in size or a decrease. However, and herein lies my problem
with this paper, only 60% of patients had any imaging past 12
months. Although survival and freedom from reintervention rates
are good, we really do not know what happened to the aortas in
these patients in the late stage. Thus, I have three other questions.
I noted that 15 patients with the Marfan syndrome were treated
and that Marfan actually in the univariate analysis was a predictor
of in-hospital death. Do you still recommend stent-graft treatment
for primary dissections in patients with Marfan syndrome?
Dr Ehrlich. Thank you, Dr. Mitchell, for this excellent com-
ment. Fifteen patients with Marfan syndrome were included in
the study. Two of them had acute complicated type B dissection,
in which I see the only indication for stent-graft placement probably
as a bridging procedure to late elective surgery. The other 13 pa-
tients had chronic type B dissection. In my personal opinion, I
would not recommend stent grafting for these patients, as they
are usually relatively young and I think they would have a relatively
low morbidity or mortality if they where to be operated on conven-
tionally.
Dr Mitchell. We concur with that entirely.
With regard to spinal cord injury, did this appear in the acute
phase or were these delayed paraplegias? Do we have any infor-124 The Journal of Thoracic and Cardiovascular Surmation as to the distal extent of your stent grafts? We are partic-
ularly paranoid about allowing our stent grafts below the T6 or T7
level.
Dr Ehrlich. Spinal cord injury developed in 4 patients, and the
injury occurred right after stent-graft placement. There were no in-
stances of delayed onset of paraplegia. However, in 2 patients, the
paraplegia resolved, resulting in a permanent paraplegia rate of 2%.
It must be stressed, however, that in none of these patients was the
left subclavian artery overstented and in none of these patients were
multiple stents used.
DrMitchell. In cases of chronic dissection, do you have any in-
formation on the behavior of the false lumen or thrombosis thereof
during late follow-up?
I applaud your attempt to provide critical information on this dif-
ficult patient cohort.
Dr Ehrlich. The false lumen was thrombosed in 59% of all pa-
tients. It was partially thrombosed in 20%, and no thrombosis oc-
curred in 20%. However, we saw a trend that in acute type B
dissection the rate of false lumen thrombosis was higher.
Dr Thomas M. Beaver (Gainesville, Fla). I am curious about
the 29% incidence of endoleaks, or primary type I endoleaks, and
the reasons for reintervention. Traditionally, type B dissections
are treated medically and if the aorta is not aneurysmal, we would
not be intervening. What were the reasons for intervention on the
type I endoleaks?
Dr Ehrlich. The major finding in this study is that acute compli-
cated type B dissection can be nicely treated with a stent device;
however, in chronic type B dissection the results were very bleak
and actually comparable to medical treatment. I think our data
are confirmed by the INSTEAD* trial, or, let’s say differently,
the INSTEAD trial confirms our observation that probably patients
with chronic type B dissections are better off with medical
treatment.
Dr D. Craig Miller (Stanford, Calif). I also have reviewed this
paper. The results in the patients with complicated acute type B
dissections, people dying right under your nose, are superb. You
do have some 1- to 2-year data that show this is really where this
technology is going to save lives. Conversely, you have not per-
suaded me that stent grafting offers any favorable effects or protec-
tion for patients with chronic uncomplicated dissections. Just
because stent grafting can be done with low morbidity and mortal-
ity risk does not mean it should be done.
Dr Ehrlich. I fully agree with you.
Dr Miller. Your coauthors may not, though. This is difficult for
Marek as he is representing a very diverse group of interventional
radiologists and cardiologists and cardiac surgeons from many dif-
ferent centers.* INSTEAD= INvestigation of STEnt grafts in patients with type B Aortic Dissection.
gery c July 2009
